Artificial pancreas and algorithm improve treatment for type 1 diabetes | KurzweilAI | Longevity science | Scoop.it

The first trial comparing a new dual-hormone “artificial pancreas” with conventional diabetes treatment using an insulin pump has been completed by researchers at IRCM (Institut de Recherches Cliniques) of Montreal, led by endocrinologist Dr. Rémi Rabasa-Lhoret. It showed improved glucose levels and lower risks of hypoglycemia.